Set as preferred source
Insights from State of Insurtech: Global | 2025 recap.
Insurtech funding rebounded to $5.3B, but capital is concentrating into fewer, later-stage companies. The US is extending control into underwriting infrastructure, while incumbents govern scaling through partnerships. Innovation is no longer the constraint—capital allocation and integration pathways now determine market structure.
Executive overview
Insurtech is no longer an expansion-driven innovation market. The 2025 data signals a structural transition toward capital discipline, where funding remains available but is selectively deployed into companies that can operate within existing insurance systems.
The shift is not about reduced innovation—it is about redefined constraints. The bottleneck has moved from technological feasibility to institutional compatibility. Capital allocation, distribution control, and integration capability now determine which companies scale and where value accrues.
This marks a transition from a venture-led disruption cycle to an institutionally governed ecosystem. Innovation persists, but scaling is externally mediated—shaped by incumbents, constrained by infrastructure, and filtered through capital concentration.
Strategic signals
Capital recovery without ecosystem expansion
Global insurtech funding increased 10% year-over-year to $5.3B, marking the first uptick since 2021. However, deal volume declined 11% to 405 transactions.
This divergence is structural. Capital is returning, but participation is narrowing. Fewer companies are absorbing a larger share of funding, signaling a shift from ecosystem expansion to capital concentration.
Investor participation is compressing
Only 15 investors made four or more insurtech investments in 2025—the lowest level in nearly a decade.
This reflects a transition from broad participation to high-conviction capital. Investment is no longer exploratory—it is selective, concentrated, and oriented toward companies already aligned with institutional systems.
Capital is shifting from discovery to execution
Only 24% of deals went to early-stage companies, compared to 46% across the broader venture market.
Capital is no longer funding discovery. It is funding execution—specifically, the ability to integrate into legacy infrastructure, operate within regulatory constraints, and scale within incumbent-controlled environments.
The governing question has shifted from possibility to compatibility.
Mega-rounds are pre-emptive filters, not accelerators
The number of $100M+ rounds nearly doubled, reinforcing a structural dynamic where capital pre-selects category leaders early.
These rounds function as gatekeeping mechanisms. They concentrate resources, define winners in advance, and compress competitive formation cycles.
Capital is not responding to market outcomes—it is shaping them upstream.
Deal size expansion signals risk standardization
Average deal size increased 13% to $15.2M, reflecting fewer but more validated investments.
This is not a return to aggressive growth—it is a shift toward risk standardization. Capital is being deployed into companies that meet predefined thresholds of commercial maturity and system compatibility.
US dominance is evolving into infrastructure control
The US accounts for roughly half of all insurtech deals and leads across funding, mega-rounds, and exits.
More critically, this dominance extends into underwriting models, data flows, and pricing architectures. This positions the US as the locus of control over how insurance systems are designed and operated globally.
Capital concentration is translating into standard-setting power.
Sector divergence reflects where complexity concentrates
Funding recovery is uneven. Property & Casualty (P&C) saw a 28% increase, while life & health remains constrained.
Capital is concentrating in segments where risk is more complex, volatile, and data-intensive—particularly cyber and commercial lines. These areas offer greater leverage for advanced underwriting and infrastructure-driven differentiation.
Talent allocation is aligning with capital intensity
Headcount growth is strongest in cyber insurance, commercial P&C, and supporting infrastructure layers.
Labor is reallocating toward segments where underwriting complexity is highest and where capital is most concentrated. Talent flows are reinforcing structural capital signals.
Partnerships institutionalize modular dependency
Large carriers are increasingly partnering with insurtechs ranked in the top ~7% of performance benchmarks.
This is not opportunistic—it is systemic. Partnerships are now the primary mechanism of innovation deployment, creating a modular ecosystem where startups provide capabilities but incumbents control distribution and infrastructure.
Scaling is no longer autonomous. It is mediated.
Exit pathways are selective and institutionally gated
Exit activity remains dominated by M&A, with IPO probability concentrated among a small number of mature companies (~58% for leading candidates).
Liquidity is constrained and conditional. Outcomes are determined by alignment with institutional buyers or by achieving a narrow band of scale and performance required for public markets.
Thematic deep dives
Capital allocation: from market discovery to structural control
The defining shift is not the return of capital—but its role.
Capital is no longer enabling broad innovation. It is functioning as a structural control layer, concentrating resources into a limited set of companies and pre-defining competitive outcomes.
Mega-rounds act as allocation signals that shape market structure before competition fully develops. This reduces uncertainty but compresses optionality across the ecosystem.
Market leadership is increasingly determined at the point of capital deployment.
Market structure: institutional governance and modular dependency
Insurtech is converging into an institutionally governed system.
Incumbents are not being displaced—they are orchestrating innovation through partnerships. Startups operate as modular providers of capability, while incumbents retain control over distribution, underwriting, and customer access.
This creates a system of modular dependency. Innovation exists, but scaling pathways are externally controlled.
The result is a shift from competitive disruption to coordinated integration.
Regional asymmetry: capital concentration as system control
Geographic concentration is now inseparable from infrastructure control.
US-based ecosystems are not only attracting capital—they are defining underwriting logic, data architectures, and risk models that shape global insurance markets.
Regions with lower capital density participate within these systems but do not define them. This creates asymmetry in both economic outcomes and strategic influence.
Control over capital is becoming control over the system itself.
Innovation maturity: integration as the binding constraint
Innovation is no longer limited by technological capability. It is limited by the ability to integrate.
Companies must align with regulatory frameworks, legacy systems, and incumbent workflows. Success depends on embedding into existing infrastructure rather than building parallel systems.
This reframes innovation from invention to execution within constraints.
Exit environment: consolidation as structural outcome
The exit environment reinforces institutional control.
With IPO pathways limited and selective, M&A has become the dominant mechanism for value realization. Incumbents are acquiring capabilities to extend their control over infrastructure and distribution.
This creates a reinforcing loop: consolidation strengthens incumbents, which further shapes how innovation is deployed and monetized.
Competitive or ecosystem snapshot
Advantaged:
- Large incumbents controlling distribution, underwriting infrastructure, and integration pathways
- Late-stage insurtechs aligned with capital concentration and institutional demand
- High-conviction investors shaping market structure through selective allocation
Constrained:
- Early-stage companies facing reduced capital access and higher integration thresholds
- Life & health segments with slower capital recovery and lower investor priority
- Non-US ecosystems with limited influence over underwriting standards and infrastructure
Risk radar
Capital concentration risk
Pre-selection of winners reduces systemic resilience and narrows strategic optionality.
Innovation pipeline compression
Reduced early-stage investment limits long-term differentiation capacity.
Institutional dependency risk
Modular dependency shifts bargaining power toward incumbents controlling infrastructure.
Exit liquidity constraints
Selective IPO pathways and M&A reliance constrain value realization.
Infrastructure concentration risk
Control over underwriting systems and data flows becomes geographically centralized.
Strategic implications
- Insurtech is transitioning from a venture-driven market to a capital-allocated, institutionally governed system.
- Capital is defining competitive outcomes earlier, reducing market fluidity and discovery.
- Modular dependency is replacing standalone scaling as the dominant operating model.
- Sector divergence is concentrating capital and talent in high-complexity underwriting domains.
- Geographic concentration is translating into control over global insurance infrastructure and standards.
